|
Boix F, Llorente S, Mrowiec A, Eguia J, López-Hernández R, Bernardo MV, Moya-Quiles MR, Campillo JA, Minguela A, Jimeno L, Alvarez-López MR, Muro M. Donor specific antibodies median fluorescence intensity levels are the best indicator for monitoring desensitization treatment in kidney transplant. Urol J. 2014 Jul 8;11(3):1695-8. PubMed PMID: 25015619.
AÑO: 2014; IF: 0.565
|
25015619
|
López-Hernández R, Valdés M, Campillo JA, Martínez-García P, Salama H, Bolarin JM, Martínez H, Moya-Quiles MR, Minguela A, Sánchez-Torres A, Botella C, Salgado G, Miras M, Carballo F, Muro M. Pro- and anti-inflammatory cytokine gene single-nucleotide polymorphisms in inflammatory bowel disease. Int J Immunogenet. 2015 Feb;42(1):38-45. doi: 10.1111/iji.12160. PubMed PMID: 25359546.
AÑO: 2015; IF: 1.174
|
|
Campillo JA, López-Hernández R, Martínez-Banaclocha H, Bolarín JM, Gimeno L, Mrowiec A, López M, Las Heras B, Minguela A, Moya-Quiles MR, Legáz I, Frías-Iniesta JF, García-Alonso AM, Álvarez-López MR, Martínez-Escribano JA, Muro M. MHC class I chain-related gene a diversity in patients with cutaneous malignant melanoma from southeastern Spain. Dis Markers. 2015;2015:831864. doi: 10.1155/2015/831864. PubMed PMID: 25838620; PubMed Central PMCID: PMC4370202.
AÑO: 2015; IF: 2.137
|
|
Martínez-Sánchez MV, Periago A, Legaz I, Gimeno L, Mrowiec A, Montes-Barqueros NR, Campillo JA, Bolarin JM, Bernardo MV, López-Álvarez MR, González C, García-Garay MC, Muro M, Cabañas-Perianes V, Fuster JL, García-Alonso AM, Moraleda JM, Álvarez-Lopez MR, Minguela A. Overexpression of KIR inhibitory ligands (HLA-I) determines that immunosurveillance of myeloma depends on diverse and strong NK cell licensing. Oncoimmunology. 2015 Oct 29;5(4):e1093721. eCollection 2016 Apr. PubMed PMID: 27141379; PubMed Central PMCID: PMC4839374.
AÑO: 2016; IF: 7.719
|
|
Boix F, Bolarín JM, Eguía J, Gonzalez-Martinez G, De La Peña J, Galian JA, Hernández-Martínez AM, Moya-Quiles MR, Legaz I, Campillo JA, Ramirez P, Sanchez-Bueno F, García-Alonso AM, Pons JA, Minguela A, Llorente S, Muro M. Pretransplant CD28 Biomarker (Levels of Expression and Quantification of Molecules per Cell) in Peripheral CD4(+) T Cells Predicts Acute Rejection Episodes in Liver and Kidney Recipients. Transplant Proc. 2016 Nov;48(9):2987-2989. doi: 10.1016/j.transproceed.2016.09.028. PubMed PMID: 27932126.
AÑO: 2016; IF: 0.908
|